Entrada Therapeutics (TRDA) Q4 2023 Earnings

13MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.9
-0.6
-0.3
0

Details

Expected EPS
-0.16842
Actual EPS
-0.29
Surprise EPS
-0.12
Surprise Percent
+72.19%

Description

Entrada Therapeutics (TRDA) has reported earnings of -0.29 per share for Q4 2023.

0 Comments

Share your thoughts